If youre already having B12 injections or considering them, its essential to understand what type of B12 youre receiving and why it matters
BPC-157 is not approved by the Therapeutic Goods Administration (TGA) and is prohibited by the World Anti-Doping Agency (WADA)
Loading phase protocol (acute injury or initial treatment): Dose: 500 mcg to 1 mg per injection Frequency: Once daily Duration: 7 to 10 days Injection site: Subcutaneous, ideally near the area of concern Timing: Morning or evening, consistency matters more than specific time Maintenance phase protocol: Dose: 500 mcg to 1 mg per injection Frequency: 2 to 3 times per week Duration: 4 to 8 weeks total protocol length Cycle recommendation: 2 months on, 2 months off Unlike traditional BPC-157 acetate, which is often administered twice daily due to its shorter half-life, the enhanced stability of the arginate form typically allows for once-daily dosing during the loading phase
Research and practice in thrombosis and haemostasis
This is a sterile, non-pyrogenic, deionized water that contains 0.9% benzyl alcohol (9 mg/ml) added as a bacteriostatic preservative
Melbourne sports chiropractor, Dr